Realizing Public Rights Through Government Patent Use

Journal of Law, Medicine and Ethics 49 (1):34-38 (2021)
  Copy   BIBTEX

Abstract

A substantial portion of biomedical R&D is publicly funded. But resulting medicines are typically covered by patents held by private firms, and priced without regard to the public’s investment. The Bayh-Dole Act provides a possible remedy, but its scope is limited.

Categories

Keywords

Reprint years

DOI

10.1017/jme.2021.7

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,219

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Liberalism and intellectual property rights.Hugh Breakey - 2009 - Politics, Philosophy and Economics 8 (3):329-349.
Ethico-legal issues in biomedicine patenting: A patent professional viewpoint.R. Stephen Crespi - 2005 - Science and Engineering Ethics 11 (1):117-136.
Patents and Human Rights: A Heterodox Analysis.E. Richard Gold - 2013 - Journal of Law, Medicine and Ethics 41 (1):185-198.
Before the house of lords.Justine Pila - unknown
The Stakes in Bayh-Dole: Public Values Beyond the Pace of Innovation.Walter D. Valdivia - 2011 - Minerva 49 (1):25-46.
Pesticides and the Patent Bargain.Cristian Timmermann - 2015 - Journal of Agricultural and Environmental Ethics 28 (1):1-19.
Asserting The Primacy of Health Over Patent Rights: A Comparative Study of the Processes that Led to the Use of Compulsory Licensing in Thailand and Brazil.Stephanie T. Rosenberg - 2014 - Developing World Bioethics 14 (2):83-91.
Patent rights or patent wrongs? The case of patent rights on AIDS drugs.Paul Davey Samantha Byrne - 2006 - Business Ethics, the Environment and Responsibility 15 (3):299-305.
Balancing access to pharmaceuticals with patent rights.Dianne Nicol - 2003 - Monash Bioethics Review 22 (2):S50-S62.
Ethical reasons for narrowing the scope of biotech patents.Tom Andreassen - 2015 - Medicine, Health Care and Philosophy 18 (4):463-473.
Patents and access to drugs in developing countries: An ethical analysis.Sigrid Sterckx - 2004 - Developing World Bioethics 4 (1):58–75.
Patents and Access to Drugs in Developing Countries: An Ethical Analysis.Sigrid Sterckx - 2004 - Developing World Bioethics 4 (1):58-75.
Patent rights or patent wrongs? The case of patent rights on AIDS drugs.Samantha Byrne, Paul Davey, Kirsti McFarlane, John O'Brien & Craig Templeton - 2006 - Business Ethics: A European Review 15 (3):299-305.
Patent rights or patent wrongs? The case of patent rights on AIDS drugs.Samantha Byrne, Paul Davey, Kirsti McFarlane, John O'Brien & Craig Templeton - 2006 - Business Ethics, the Environment and Responsibility 15 (3):299–305.
Alienation from the Objectives of the Patent System: How to Remedy the Situation of Biotechnology Patent.Li Jiang - 2019 - Science and Engineering Ethics 25 (3):791-811.

Analytics

Added to PP
2021-04-22

Downloads
8 (#1,249,165)

6 months
5 (#544,079)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

Add more citations

References found in this work

No references found.

Add more references